364-05-008 ISMRM Abstract

Time-Dependent Diffusion MRI for Predicting IDH Mutation and Exploring Underlying Biological Mechanisms

Primary: Neuro - Tumors

Secondary: Diffusion - Microstructure

364-05-008 · Classification in Diffusion MRI I · Monday, 11 May, 4:10 PM–5:05 PM · Digital Posters Row E

Keywords: Glioma Time-dependent diffusion MRI T-cell infiltration Single-cell analysis

Accepted

Wanjun Hu ¹, Darui Li², Yuhui Xiong³, Lizhi Xie^3,4,5,6,7, Jing Zhang^1,8,9,10

¹Department of Magnetic Resonance, Lanzhou, China

²Department of Magnetic Resonance,, Department of Magnetic Resonance, Lanzhou, China

³GE HealthCare MR Research, Beijing, China

⁴GE Healthcare, Beijing, China

⁵GE Healthcare, Beijing, China

⁶GE Healthcare, MR Research China, Beijing, 100176, P.R. China, China

⁷MRI Research, GE Healthcare, Beijing, China

⁸The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China

⁹Gansu Province Clinical Research Center for Functional and Molecular Imaging, Lanzhou, China, Department of Magnetic Resonance, Lanzhou, China

¹⁰Gansu Province Clinical Research Center for Functional and Molecular Imaging, Lanzhou, China, Department of Magnetic Resonance, Lanzhou, China

Presenting Author: Wanjun Hu

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Hoffmann E, Masthoff M, Kunz WG, Seidensticker M, Bobe S, Gerwing M, Berdel WE, Schliemann C, Faber C, Wildgruber M. Multiparametric MRI for characterization of the tumour microenvironment. Nature Reviews Clinical Oncology 2024;21(6):428-448. doi: 10.1038/s41571-024-00891-1 [doi]

2. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology 2021;23(8):1231-1251. doi: 10.1093/neuonc/noab106 [doi]

3. Huang Y, Shan Y, Zhang W, Printzis C, Pesce L, Stover D, Stanhope C, Stranger BE, Huang RS. Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment. Neuro Oncol 2025;27(2):430-444. doi: 10.1093/neuonc/noae207 [doi]

4. Li G, Li L, Li Y, Qian Z, Wu F, He Y, Jiang H, Li R, Wang D, Zhai Y, Wang Z, Jiang T, Zhang J, Zhang W. An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain 2022;145(3):1151-1161. doi: 10.1093/brain/awab340 [doi]

5. Niu W, Yan J, Hao M, Zhang Y, Li T, Liu C, Li Q, Liu Z, Su Y, Peng B, Tan Y, Wang X, Wang L, Zhang H, Yang G. MRI transformer deep learning and radiomics for predicting IDH wild type TERT promoter mutant gliomas. npj Precision Oncology 2025;9(1). doi: 10.1038/s41698-025-00884-y [doi]

6. Bhatia A, Moreno R, Reiner AS, Nandakumar S, Walch HS, Thomas TM, Nicklin PJ, Choi Y, Skakodub A, Malani R, Prabhakaran V, Tiwari P, Diaz M, Panageas KS, Mellinghoff IK, Bale TA, Young RJ. Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma. Clin Cancer Res 2024;30(1):106-115. doi: 10.1158/1078-0432.Ccr-23-1180 [doi]

7. Cluceru J, Interian Y, Phillips JJ, Molinaro AM, Luks TL, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Shai A, Chunduru P, Pedoia V, Villanueva-Meyer JE, Chang SM, Lupo JM. Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging. Neuro-Oncology 2022;24(4):639-652. doi: 10.1093/neuonc/noab238 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/364-05-008